Indeglitazar | Interleukin Related interleukin-related.com

Product Name :
Indeglitazar

Search keywords :
Indeglitazar

drugId :
null

Target Vo:
Peroxisome proliferator-activated receptor γ

Target Vo Short Name :
PPARγ

Moa_Name:
Peroxisome proliferator-activated receptor delta agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :
Phase 2 Clinical

China Termination Status :
Phase 2 Clinical

Highest Status:
Discontinued

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKC delta Antibody
Phospho-FAK (Tyr397) Antibody
Thymidylate Synthase Antibody: Thymidylate Synthase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to thymidylate synthase. It can be used for WB, IHC-F, IHC-P, ICC/IF, IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts